Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation

Programmed cell death ligand-1 (PD-L1), expressed on both tumor cells (TC) and tumor-associated immune cells (IC), has been shown to be a useful biomarker and predictive of response to anti-PD-L1 agents in certain tumor types. In recurrent or metastatic head and neck squamous cell carcinoma (R/M HNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildsmith, Sophie, Ye, Jiabu, Franks, April, Melillo, Giovanni, Armstrong, Jon, Whiteley, Jessica, Schnittker, Karina, Lian, Fangru, Roland, Bryan, Sabalos, Constantine, Ahmadi, Payam, Fayette, Jerome, Even, Caroline, Mesía, Ricard, Siu, Lillian L., Zandberg, Dan P., Walker, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973403/
https://www.ncbi.nlm.nih.gov/pubmed/36860696
http://dx.doi.org/10.1158/2767-9764.CRC-21-0032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973403/
https://www.ncbi.nlm.nih.gov/pubmed/36860696
http://dx.doi.org/10.1158/2767-9764.CRC-21-0032

Ejemplares similares